Filing Flows

Filing Flows › Companies › Fractyl Health › Cash flow

Fractyl Health cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$15.9M in Q2 2026 · −$82.4M over twelve months

Operating cash flow−$15.9M
Free cash flow−$15.9M

Analysis

In Q2 2026, Fractyl Health generated −$15.9M of operating cash flow. That is $5.4M more than in Q2 2025 (−$21.3M).

Over the twelve months to Jun 30, 2026, operating cash flow was −$82.4M; the largest uses were operating cash flow ($82.4M), net borrowing (+) / repaid (−) ($486K); besides operations, cash came from other financing ($108M); the cash balance rose by $24.8M.

Operating cash flow was −$15.9M against net income of −$25.5M. The largest differences: stock-based pay +$2.5M, accrued liabilities +$1.0M, payables −$643K.

Free cash flow

Fractyl Health: free cash flow by quarterFractyl Health: free cash flow by quarter−$18.3MQ3 2024−$17.3MQ4 2024−$25.5MQ1 2025−$21.3MQ2 2025−$22.7MQ3 2025−$21.3MQ4 2025−$22.5MQ1 2026−$15.9MQ2 2026
Operating cash flow less capital spending.
Fractyl Health: operating cash flow against capital spendingFractyl Health: operating cash flow against capital spendingOperating cash flowCapital spending−$18.0M$213KQ3 2024−$17.0M$233KQ4 2024−$25.1M$448KQ1 2025−$21.2M$98KQ2 2025−$22.7M$8KQ3 2025−$21.3M$3KQ4 2025−$22.5M$0Q1 2026−$15.9M$0Q2 2026
Latest (Q2 2026): Operating cash flow −$15.9M, Capital spending $0.

Capital allocation, year by year

Fractyl Health: where the cash came from (up) and went (down), by fiscal yearFractyl Health: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedCapital spendingFY2023: Operating cash flow −$42.8MFY2023: Net borrowing $28.3MFY2023: Shares issued $52KFY2023: Capital spending −$359K$28.4MFY2023FY2024: Operating cash flow −$65.5MFY2024: Net borrowing −$187KFY2024: Shares issued $104MFY2024: Capital spending −$1.8M$104MFY2024FY2025: Operating cash flow −$90.3MFY2025: Net borrowing −$457KFY2025: Shares issued $7.1MFY2025: Capital spending −$557K$7.1MFY2025
Over these 3 years operating cash flow totalled −$199M; the largest uses were operating cash flow ($199M) and capital spending ($2.7M). Cash-flow statements as filed.

Where the cash came from and went

Fractyl Health: sources (+) and uses (−) of cash, Q2 2026Fractyl Health: sources (+) and uses (−) of cash, Q2 2026Cash drawn (+) / kept (−)$16.0MOperating cash flow−$15.9MNet borrowing (+) / repaid (−)−$127K
Fractyl Health: sources (+) and uses (−) of cash, TTM to Q2 2026Fractyl Health: sources (+) and uses (−) of cash, TTM to Q2 2026Other financing$108MOperating cash flow−$82.4MCash drawn (+) / kept (−)−$24.8MNet borrowing (+) / repaid (−)−$486KNot reconciled−$11K

From profit to cash

Fractyl Health: net income to operating cash flow, Q2 2026Fractyl Health: net income to operating cash flow, Q2 2026Net income−$25.5MDepreciation & amortization$278KStock-based pay$2.5MPayables−$643KAccrued liabilities$1.0MPrepaid and other assets$290KOperating cash flow−$15.9M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.

Every quarter

QuarterOperating cash flowCapital spendingNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q2 2026−$15.9M—−$127K—$16.0M−$15.9M
Q1 2026−$22.5M—−$123K$170K$18.4M−$22.5M
Q4 2025−$21.3M−$3K−$119K$4.7M−$3.9M−$21.3M
Q3 2025−$22.7M−$8K−$117K$477K−$55.4M−$22.7M
Q2 2025−$21.2M−$98K−$112K—$19.8M−$21.3M
Q1 2025−$25.1M−$448K−$109K$280K$25.4M−$25.5M
Q4 2024−$17.0M−$233K−$106K$173K$17.2M−$17.3M
Q3 2024−$18.0M−$213K−$58K$220K$18.1M−$18.3M

Fractyl Health: income statement and cash flow

Fractyl Health, Q4 2024: revenue $3K (-57% year over year). The chart follows the revenue to costs, profit and cash.

Fractyl Health: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.